Dr. Jerome C. Young completes first Acessa Procedure using Acessa ProVuTM in the greater Houston area: Expanding minimally invasive uterine fibroid options for women at HCA Houston Healthcare Conroe
Conroe, Texas – Acessa Health Inc., developer of the Acessa ProVu System is excited to announce that Jerome C. Young, MD, FACOG, of Conroe Women’s Associates completed the first Acessa procedure for uterine fibroids using the latest Acessa ProVu technology in the greater Houston area.
The Acessa Procedure, also known as laparoscopic radiofrequency ablation (Lap-RFA) for fibroids, is a minimally invasive procedure to treat uterine fibroids. It is a uterine-sparing alternative to hysterectomy, the current standard of care.
Studies have shown over 70% of women have uterine fibroids(1). These fibroids cause abnormal heavy menstruation, pelvic pain and bulk symptoms. The Acessa Procedure revolutionizes the standard of care for fibroids by treating almost all sizes and locations of fibroids laparoscopically – including those outside the uterine cavity and within uterine walls. The procedure uses fully-integrated Lap-RFA, ultrasound visualization and guidance mapping. Unlike myomectomy, no cutting or suturing of uterine tissue is needed. Patients typically go home the same day, experience minimal discomfort, and a return to normal activities in three to five days, compared to the typical six to eight weeks for other fibroid surgery.(2)
“At Conroe Women’s Associates, we are committed to providing patients the full spectrum of treatment options,” said Dr. Young. “I am thrilled to incorporate the Acessa Procedure for fibroids into my practice. Many patients who face fibroids suffer from multiple symptoms simultaneously, including heavy bleeding, bulk and pelvic pain. Before Acessa, when medical management (e.g., birth control) failed to help relieve their symptoms, I was often limited to only offering major surgery: hysterectomy or myomectomy. With the adoption of the Acessa Procedure, I can offer an even less invasive procedure with a much shorter recovery time and great outcomes. Our Acessa patients are experiencing a significant improvement in symptoms. We expect more and more women to choose Acessa as their preferred treatment option.”
Dr. Young explained that he and the hospital were compelled to begin offering the procedure after reviewing the comprehensive data on the procedure. Data includes over 35 publications with 750 patients studied and over 3,000 procedures performed to-date.
“Dr. Young is a terrific partner” said Kim Rodriguez, President and Chief Executive Officer of Acessa Health Inc. “We are excited that women in Conroe and the greater Houston area are now among the many that have more options, including Acessa, for symptomatic uterine fibroids.”
About Dr. Young – Dr. Jerome Clayton Young received his medical degree from Texas A&M University Health Science Center in College Station, Texas. After medical school, he received one year of Internal Medicine training at Scott and White hospital while volunteering in the Obstetrics and Gynecology department. The following year, he transferred to the OB/GYN department for his residency. Dr. Young is board certified by the American Board of Obstetricians and Gynecologist and is a fellow of the American Congress of Obstetrics and Gynecology. He is a member of the Texas Medical Association and The America Association of Physicians and Surgeons. He lives with his wife, Virginia and four children in South Montgomery County, where they have resided since completing residency a Scott and White Hospital in 1998.
About Acessa Health Inc. – Acessa Health is a women’s health innovator dedicated to advancing minimally invasive, uterine-sparing solutions for women with symptomatic fibroids. The company introduced the use of laparoscopic radiofrequency ablation for the treatment of uterine fibroids and is committed to ensuring that women have more options by developing technologies that improve the lives of its patients. Acessa Health’s headquarters are in Austin, Texas. For more information, visit AcessaProcedure.com.
- Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–107. doi: 10.1067/mob.2003.99.
- Yelena Havryliuk, MD, Robert Setton, MD, John Carlow, EdD, MPH, Barry D. Shaktman, MD, Management of Symptomatic Fibroids: Review and Meta-Analysis of the Literature (2006 -2016), Journal of the Society of Laparoendoscopic Surgeons, Vol. 21 (3) Jul-Sept 2017